Gotowa bibliografia na temat „Metastatic carcinoma”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Metastatic carcinoma”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Metastatic carcinoma"
Cheng, Shaun Kian Hong, i Khoon Leong Chuah. "Metastatic Renal Cell Carcinoma to the Pancreas: A Review". Archives of Pathology & Laboratory Medicine 140, nr 6 (1.06.2016): 598–602. http://dx.doi.org/10.5858/arpa.2015-0135-rs.
Pełny tekst źródłaSadr, AH, S. de Kerviler i N. Kang. "Cutaneous basal cell carcinoma with endobronchial metastasis". Annals of The Royal College of Surgeons of England 96, nr 7 (październik 2014): e20-e21. http://dx.doi.org/10.1308/003588414x13946184902244.
Pełny tekst źródłaÇEÇEN, Ayşe, Esra KAVAZ i Seda GÜN. "A rare case: Renal cell carcinoma metastasis to lower lip". Journal of Experimental and Clinical Medicine 38, nr 3 (23.04.2021): 396–97. http://dx.doi.org/10.52142/omujecm.38.3.38.
Pełny tekst źródłaWahyuni, Siska Dwiyantie, Sri Suryanti, Hasrayati Agustina i Bethy Suryawathy Hernowo. "The Association of Clinicopathological Features with Metastatic Status in Infiltrative Urothelial Carcinoma of Bladder". Journal of Drug Delivery and Therapeutics 10, nr 6-s (18.12.2020): 99–102. http://dx.doi.org/10.22270/jddt.v10i6-s.4647.
Pełny tekst źródłaÇEÇEN, Ayşe, Esra KAVAZ i Seda GÜN. "The clinical and prognostic value of the neutrophil lymphocyte ratio, the platelet lymphocyte ratio and mean platelet volume in tinnitus patients". Journal of Experimental and Clinical Medicine 38, nr 3 (23.04.2021): 251–54. http://dx.doi.org/10.52142/omujecm.38.3.8.
Pełny tekst źródłaLiang, Huasheng, Yuhua Zhong, Zuojie Luo, Yu Huang, Huade Lin, Min Luo, Song Zhan, Kaiqing Xie, Yan Ma i Qingdi Quentin Li. "Assessment of Biomarkers for Clinical Diagnosis of Papillary Thyroid Carcinoma with Distant Metastasis". International Journal of Biological Markers 25, nr 1 (styczeń 2010): 38–45. http://dx.doi.org/10.1177/172460081002500106.
Pełny tekst źródłaShanbhag, Nandan. "Metastatic colorectal carcinoma: Response to panitumumab". Journal of the Bahrain Medical Society 30, nr 1 (20.03.2018): 5–8. http://dx.doi.org/10.26715/jbms.1_01032018.
Pełny tekst źródłaNunez, D. A., C. G. C. Sutherland i R. K. Sood. "Breast metastasis from a pharyngeal carcinoma". Journal of Laryngology & Otology 103, nr 2 (luty 1989): 227–28. http://dx.doi.org/10.1017/s0022215100108540.
Pełny tekst źródłaXu, K., Q. Ye, L. Han i M. Zhong. "A Comparative Analysis of Immunohistochemical Profile of Primary and Metastatic Endometrial Endometrioid Carcinoma". American Journal of Clinical Pathology 154, Supplement_1 (październik 2020): S32—S33. http://dx.doi.org/10.1093/ajcp/aqaa161.066.
Pełny tekst źródłaTickoo, Satish K., Anastassios G. Pittas, Michael Adler, Melissa Fazzari, Steven M. Larson, Richard J. Robbins i Juan Rosai. "Bone Metastases From Thyroid Carcinoma". Archives of Pathology & Laboratory Medicine 124, nr 10 (1.10.2000): 1440–47. http://dx.doi.org/10.5858/2000-124-1440-bmftc.
Pełny tekst źródłaRozprawy doktorskie na temat "Metastatic carcinoma"
Nordman, Ina IC Clinical School St Vincent's Hospital Faculty of Medicine UNSW. "Surrogate endpoints of survival in metastatic carcinoma". Publisher:University of New South Wales. Clinical School - St Vincent's Hospital, 2008. http://handle.unsw.edu.au/1959.4/42791.
Pełny tekst źródłaLee, Yee-ki Carol. "Effect of dietary fatty acids on metastatic hepatocellular carcinoma /". Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B39707349.
Pełny tekst źródłaMalek, Joël. "Genetic alterations of the metastatic lesions in ovarian carcinoma". Thesis, Paris 11, 2011. http://www.theses.fr/2011PA11T109.
Pełny tekst źródłaOvarian cancer is the most deadly gynecological cancer. The high rate of mortality is due to the large tumor burden with extensive metastatic lesion of the abdominal cavity. There are few studies on genetic alterations and their consequences in peritoneal metastatic tumors when compared to their matched ovarian primary tumors. Our hypothesis is that differences between the metastatic and primary lesions might be the cause of residual disease and, most importantly may have a role in post-chemotherapeutic recurrences. Methods: We conducted integrated genomics analysis on matched primary and metastatic tumors from 9 patients. In the papers presented here we analyze genome-wide Copy Number Variations (CNVs) using SNP Arrays targeting peritoneal metastasis differences, Gene expression differences using Microarrays also targeting peritoneal metastasis differences, and for some patients, Single Nucleotide Polymorphisms (SNPs) in genes through Exome sequencing.Results: Here we show that CNVs vary significantly between primary and metastatic tumors and include genes that have been considered potential chemotherapeutic targets based on primary tumor only data. Gene expression differences, while minor, showed highly statistically significant enrichment of genes in ovarian cancer critical pathways. In agreement with findings in other cancers, exome sequencing data revealed very few SNP differences of which most metastasis enriched SNPs were present at very low levels in the primary tumor. The results presented here should allow better design of therapies to target residual ovarian cancer disease
Bartrolí, Comellas Mariona. "Prognostic markers and therapeutic targets for metastatic renal cell carcinoma". Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/664198.
Pełny tekst źródłaRecentment, l’estudi de la metàstasi ha guanyat importància amb l’objectiu d’augmentar la supervivència dels pacients amb càncer. En el càncer renal (RCC), el descobriment de biomarcadors metastàtics i dianes terapèutiques és necessari degut a que la majoria de pacients presenten metàstasi en el moment del diagnòstic. L’objectiu d’aquesta tesi ha estat el descobriment de nous biomarcadors i dianes terapèutiques pel càncer renal metastàtic a través de dues variants d’un model animal orthoxenograft (PDOX) de RCC de cèl·lula clara (ccRCC). Els models PDOX han guanyat molta importància en l’estudi de la progressió del càncer i la metàstasi, ja que mimetitzen la histologia, la capacitat metastàtica i la resposta als tractaments. Prèviament, s’havien seqüenciat les dues variants d’aquest model PDOX tant a nivell de DNA com de RNA, juntament amb un anàlisi FISH. En primer lloc, la Carbxoxipeptidasa E (CPE), un dels gens més expressats en la variant metastàtica, ha demostrat ser important en la invasió quan és secretada al medi, tot i no ser suficient per generar metàstasi in vivo. A més, s’ha associat amb el ccRCC i anti-correlacionat amb la supervivència d’aquests pacients. En segon lloc, hem estudiat dues molècules de la cascada de coagulació, una de les més alterades en nivells de RNA. Hem demostrat que el Factor XIII (FXIII o F13) està relacionat amb CPE in vivo, malgrat que l’expressió de les dues molècules no és suficient per a que es desenvolupi la metàstasi. Tot i així, el F13 afecta la supervivència de pacients amb ccRCC, suggerint aquestes dues molècules com a possibles biomarcadors d’aquest tipus de càncer. A més, la inhibició del Receptor del Factor de Coagulació II (F2R) ha demostrat reduir les fases inicials i finals del procés metastàtic. Així doncs, l’ús d’inhibidors de F2R, juntament amb el fet que la cascada de coagulació es relaciona amb el pronòstic dels pacients, fa que aquesta tesi obri noves oportunitats per al tractament de la metàstasi i la malignització del càncer. En resum, hem descobert nous biomarcadors i dianes terapèutiques que, juntament amb futures validacions, sobretot en clínica, poden ser útils per als pacients metastàtics de ccRCC.
Pilborough, Alice Elizabeth. "Tumour-stromal crosstalk in metastatic lymph nodes of oral squamous cell carcinoma". Thesis, University of Sheffield, 2018. http://etheses.whiterose.ac.uk/22053/.
Pełny tekst źródłaHo, Chi-lai, i 何志禮. "Dual-tracer positron emission tomography in the evaluation ofprimary & metastatic hepatocellular carcinoma". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B45205024.
Pełny tekst źródłaGriffin, Ryan D. "MULTISPECTRAL CO-OCCURRENCE ANALYSIS FOR AUTOMATED TUMOR DETECTION IN METASTATIC MEDULLARY THYROID CARCINOMA". The Ohio State University, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=osu1285101309.
Pełny tekst źródłaOkuno, Tomoko. "Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma". Kyoto University, 2011. http://hdl.handle.net/2433/142555.
Pełny tekst źródłaKerr, Ian Balfour. "A study of metastasis in colorectal carcinoma using DNA recombinant and molecular hybridisation techniques". Thesis, University of Edinburgh, 1989. http://hdl.handle.net/1842/19010.
Pełny tekst źródłaSwofford, Brenen P., i Tomislav Dragovich. "Durable and Complete Response to Herceptin Monotherapy in Patients with Metastatic Gastroesophageal Cancer". KARGER, 2017. http://hdl.handle.net/10150/626424.
Pełny tekst źródłaKsiążki na temat "Metastatic carcinoma"
Warner, Ellen. Phase I - II study of vinblastine and oral cyclosporin a in metastatic renal cell carcinoma. Ottawa: National Library of Canada, 1996.
Znajdź pełny tekst źródłaInternational, Symposium on Cellular Oncology (2nd 1985 Palm Springs Calif ). Occult nodal metastasis in solid carcinomata. New York: Praeger, 1987.
Znajdź pełny tekst źródłaOral cancer metastasis. New York: Springer, 2010.
Znajdź pełny tekst źródłaHoogewoud, H. M. Hepatocellular carcinoma and liver metastases: Diagnosis and treatment. Berlin: Springer-Verlag, 1993.
Znajdź pełny tekst źródłaMcElligott, Anthony M. The role of matrix metalloproteinases and their inhibitors, the tissue inhibitors of metalloproteinases, in renal cell carcinoma cell invasion and metastasis. [S.l: The Author], 1999.
Znajdź pełny tekst źródłaSurgical Treatment of Metastatic Renal Cell Carcinoma. Derman Tıbbi Yayıncılık, 2015. http://dx.doi.org/10.4328/derman.9786055121242.
Pełny tekst źródłaA, Stein Cy, i National Cancer Institute (U.S.). Office of Cancer Communications, red. Suramin, an active agent in metastatic adrenocortical carcinoma. [Bethesda, Md.?]: National Cancer Institute, Office of Cancer Communications, 1988.
Znajdź pełny tekst źródłaHuang, William C., i Ezequiel Becher. Advanced and Metastatic Renal Cell Carcinoma an Issue of Urologic Clinics. Elsevier, 2020.
Znajdź pełny tekst źródłaCalabrò, Fabio, i Cora N. Sternberg. Treatment of metastatic bladder cancer. Redaktor James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0079.
Pełny tekst źródłaMassey, Veta Hamblen. RELATIONSHIP BETWEEN POWERLESSNESS, HARDINESS, DIAGNOSIS, AND HOPELESSNESS IN PERSONS HOSPITALIZED FOR CHOLECYSTECTOMY OR METASTATIC CARCINOMA. 1989.
Znajdź pełny tekst źródłaCzęści książek na temat "Metastatic carcinoma"
Casadei, Roberto, i Marco Gambarotti. "Metastatic Carcinoma". W Atlas of Musculoskeletal Tumors and Tumorlike Lesions, 251–55. Cham: Springer International Publishing, 2013. http://dx.doi.org/10.1007/978-3-319-01748-8_55.
Pełny tekst źródłaNakashima, Toshiro, i Masamichi Kojiro. "Metastatic Liver Cancers". W Hepatocellular Carcinoma, 245–53. Tokyo: Springer Japan, 1987. http://dx.doi.org/10.1007/978-4-431-68334-6_16.
Pełny tekst źródłaBacchini, Patrizia, i Franco Bertoni. "Metastatic Bone Carcinoma". W Tumors and Tumor-Like Lesions of Bone, 601–8. London: Springer London, 2015. http://dx.doi.org/10.1007/978-1-4471-6578-1_46.
Pełny tekst źródłaBacchini, Patrizia, i Franco Bertoni. "Metastatic Bone Carcinoma". W Tumors and Tumor-Like Lesions of Bone, 603–9. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-28315-5_49.
Pełny tekst źródłaTsakayannis, D. E., i Dimitrios A. Linos. "Metastatic Adrenocortical Carcinoma". W Adrenal Glands, 151–57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2005. http://dx.doi.org/10.1007/3-540-26861-8_15.
Pełny tekst źródłaMcGregor, Bradley A., i Guru P. Sonpavde. "Management of Metastatic Penile Cancer". W Penile Carcinoma, 125–32. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-82060-2_11.
Pełny tekst źródłaSuzuki, Ayana, Mitsuyoshi Hirokawa i Aki Tanaka. "Metastatic Renal Cell Carcinoma". W Thyroid FNA Cytology, 399–403. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-1897-9_51.
Pełny tekst źródłaPradhan, Tapaswani, i Sudhir Bahadur. "Metastatic Neck Disease". W Carcinoma of the Larynx and Hypopharynx, 41–61. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-3110-7_4.
Pełny tekst źródłaSong, Won Hoon, i Hyeong Dong Yuk. "Treatment of Metastatic Bladder Cancer". W Management of Urothelial Carcinoma, 123–37. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-10-5502-7_12.
Pełny tekst źródłaPowles, Tom, i Axel Bex. "Integration of Surgery in Metastatic Renal Cancer". W Renal Cell Carcinoma, 257–77. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-062-5_15.
Pełny tekst źródłaStreszczenia konferencji na temat "Metastatic carcinoma"
Gupta, Vivek, Amita Mishra, Namit Kalra i Bhawna Narula. "A rare case report of incidental solitary uterine metastasis in primary invasive lobular carcinoma of breast". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685401.
Pełny tekst źródłaSingh, Gajender, Sant Parkash Kataria i Rajeev Sen. "Carcinoma uterine cervix metastasis to the skin: A rare case report". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685280.
Pełny tekst źródłaVallabhaneni, Akhil, i Jennifer W. Toth. "Metastatic Primary Airway Adenoid Cystic Carcinoma". W American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a5893.
Pełny tekst źródłaMishra, Amita, Archit Pandit, Namit Kalra i Bhawna Narula. "Primary signet ring cell mucinous carcinoma ovary: A very rare neoplasm". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685405.
Pełny tekst źródłaCoutinho-Camillo, Cláudia M., Renato D. Puga, Cibele P. Nagano, Yukie Sato-Kuwabara, Felipe D'Almeida Costa, Clóvis A. Lopes Pinto, Luiz P. Kowalski, Fernando A. Soares i Silvia V. Lourenço. "Abstract 4005: microRNA profiles in metastatic versus non-metastatic salivary mucoepidermoid carcinoma". W Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4005.
Pełny tekst źródłaYıldız, Pınar, Sariha Buyukluoglu i Mesut Bayraktaroğlu. "Bilateral chylothorax due to gastric carcinoma and metastatic prostate carcinoma: Case reports". W ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2020.
Pełny tekst źródłaYadav, Sushma. "Unusual clinical presentation of chriocarcinoma in young patients – Neulological meatastasis". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685389.
Pełny tekst źródłaLiu, Ping, Xiaomin Ren i Lisa X. Xu. "Alternate Cooling and Heating Thermal Physical Treatment: An Effective Strategy Against MDSCs in 4T1 Mouse Mammary Carcinoma". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80229.
Pełny tekst źródłaShah, Swati, Shveta Giri, Rupinder Sekhon i Sudhir Rawal. "Inguinal lymphadenopathy as a presentation for ovarian cancer". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685329.
Pełny tekst źródłaLees, Katherine, Jamie Van Gompel i Jeffrey Janus. "Metastatic Oropharyngeal Squamous Cell Carcinoma to the Cavernous Sinus". W 29th Annual Meeting North American Skull Base Society. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1679681.
Pełny tekst źródłaRaporty organizacyjne na temat "Metastatic carcinoma"
Bhatia, Pardeep. Study of RANKL Expression in Metastatic Breast Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2003. http://dx.doi.org/10.21236/ada418749.
Pełny tekst źródłaBhatia, Pardeep. Study of RANKL Expression in Metastatic Breast Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, czerwiec 2002. http://dx.doi.org/10.21236/ada405313.
Pełny tekst źródłaSahin, Aysegul A. Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin. Fort Belvoir, VA: Defense Technical Information Center, październik 2001. http://dx.doi.org/10.21236/ada411291.
Pełny tekst źródłaSahin, Aysegul A. Treatment of Metastatic Breast Carcinoma Refactory to Doxorubicin with Liposomal-Annamycin. Fort Belvoir, VA: Defense Technical Information Center, październik 1999. http://dx.doi.org/10.21236/ada391551.
Pełny tekst źródłaSahin, Aysegul A. Treatment of Metastatic Breast Carcinoma Refractory to Doxorubicin with Liposomal-Annamycin. Fort Belvoir, VA: Defense Technical Information Center, październik 2000. http://dx.doi.org/10.21236/ada393780.
Pełny tekst źródłaDolan, Brian P. A Novel Therapeutic Vaccine for Metastatic Mammary Carcinoma: Focusing MHC/Peptide Complexes to Lipid Rafts. Fort Belvoir, VA: Defense Technical Information Center, maj 2005. http://dx.doi.org/10.21236/ada437901.
Pełny tekst źródłaQian, Jiekun, Zhangwei Tong, Yannan Zhang i Chun Chen. Immunotherapy vs platinum for advanced or metastatic thymic carcinoma: A systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, listopad 2020. http://dx.doi.org/10.37766/inplasy2020.11.0060.
Pełny tekst źródłaKufe, Donald. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2004. http://dx.doi.org/10.21236/ada429626.
Pełny tekst źródłaKufe, Donald W. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2006. http://dx.doi.org/10.21236/ada459218.
Pełny tekst źródłaKufe, Donald W. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, lipiec 2007. http://dx.doi.org/10.21236/ada548399.
Pełny tekst źródła